Skip to main content
OpenTrials

Clinical trial condition

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

1,800 public trials 303 recruiting studies
Refine in advanced search Browse all conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Recruiting

Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies

NCT06316427

Conditions
Acute Lymphoblastic Leukemia, in Relapse, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Beijing GoBroad Hospital Beijing, Beijing Municipality, China
  • Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine Shanghai, Shanghai Municipality, China
  • Shanghai Liquan Hospital Shanghai, Shanghai Municipality, China
  • The General Hospital of Western Theater Command PLA Chengdu, Sichuan, China
View Trial Details
Recruiting

A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies

NCT07070323

Conditions
Acute Lymphoblastic Leukemia, in Relapse, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Beijing GoBroad Hospital Beijing, Beijing Municipality, China
  • Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai Shanghai, Shanghai Municipality, China
  • Shanghai Liquan Hospital Shanghai, Shanghai Municipality, China
  • The General Hospital of Western Theater Command PLA Chengdu, Sichuan, China
View Trial Details
Recruiting

Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies

NCT06508775

Conditions
Acute Lymphatic Leukemia, B-cell Non Hodgkin Lymphoma, Childhood Non-Hodgkin Lymphoma, +34 more
Locations
  • Charité Universitätsmedizin Berlin Berlin, Germany
  • Universitätsklinikum Köln Cologne, Germany
  • Uniklinikum Erlangen Erlangen, Germany
  • Universitätsmedizin Göttingen Göttingen, Germany
View Trial Details
Recruiting

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

NCT04260022

Conditions
B Cell Precursor Type Acute Leukemia, Blast Crisis, Bone Marrow Diseases, +35 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Augusta Cancer Center Augusta, Georgia, United States
View Trial Details

Related conditions